2013
DOI: 10.1155/2013/640632
|View full text |Cite
|
Sign up to set email alerts
|

Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study

Abstract: Aim. To understand glucose lowering therapeutic strategies of French general practitioners (GPs) in the management of type 2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD). Methods. A multicenter cross-sectional study was conducted from March to June 2011 among a sample of French GPs who contribute to the IMS Lifelink Disease Analyzer database. Eligible patients were those with T2DM and moderate-to-severe CKD who visited their GPs at least once during the study period. Data were collected … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 15 publications
1
16
0
Order By: Relevance
“…Additionally, affected patients have an increased risk of complications, such as hypertension, anemia, malnutrition, bone and mineral disorders, retinopathy and neuropathy, and thus suffer extra morbidity and mortality [9,10]. There is also an even higher prevalence of hypoglycemia due to decreased clearance of antidiabetic agents or impaired renal gluconeogenesis, and progressive renal dysfunction reduces drug elimination and prolongs exposure to higher drug levels [11].…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, affected patients have an increased risk of complications, such as hypertension, anemia, malnutrition, bone and mineral disorders, retinopathy and neuropathy, and thus suffer extra morbidity and mortality [9,10]. There is also an even higher prevalence of hypoglycemia due to decreased clearance of antidiabetic agents or impaired renal gluconeogenesis, and progressive renal dysfunction reduces drug elimination and prolongs exposure to higher drug levels [11].…”
Section: Introductionmentioning
confidence: 99%
“…Health consequences are substantial, with sufferers at increased risk of all-cause and cardiovascular mortality, progression to kidney failure, cardiovascular disease (CVD) and hospitalizations [ 2 , 3 ]. For patients with diabetes and CKD, the risk of hypertension, anemia, malnutrition, bone and mineral disorders, and retinopathy is higher as compared to patients with normal renal function [ 4 , 5 ]. There is an even higher prevalence of hypoglycemia due to decreased clearance of hypoglycemic agents or impaired renal gluconeogenesis [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Patients with both CKD and T2D had a higher incidence of cardiovascular disease than CKD patients without T2D, which is consistent with a previous study. 31 Increased blood volume and vascular resistance resulting. From insulin resistance in T2D might contribute to the development of HTN.…”
Section: Discussionmentioning
confidence: 99%